DaVita to respond to subpoena tied to Medicare fraud probe

December 2008
Medical Device Daily;12/16/2008, Vol. 12 Issue 223, p4
The article reports that DaVita has responded to subpoena tied to a Medicare fraud probe. The company is working with the U.S. Department of Health and Human Services, Office of Inspector General (OIG), to provide documents in connection with the civil investigation by the Department of Justice and the U.S. Attorney's Office for the Northern District of Georgia. The company also is planning to meet with representatives of the government to discuss the scope of the subpoena.


Related Articles

  • DaVita to receive inquiry from HHS on dialysis drug payments.  // Medical Device Daily;10/26/2011, Vol. 15 Issue 205, p4 

    The article reports on the administrative subpoena facing DaVita from the Office of Inspector General for the U.S. Department of Health and Human Services in relation to an inquiry into payment for infusion drugs covered by the New York Medicaid composite payment system for dialysis.

  • OIG Always Looking at 'Emerging Fraud Trends,' Reps Reveal.  // Part B Insider;10/27/2012, Vol. 13 Issue 38, p297 

    The article offers information regarding investigation of emerging fraud cases related to Medicare and Medicaid at the Office of the Inspector General (OIG), the U.S. Department of Health and Human Services (HSS). It further discusses the views of Gloria Jarmon, Deputy Inspector General for...

  • Feds Train Fraud Spotlight On Home Care.  // Eli's Home Care Week;4/30/2012, Vol. 21 Issue 16, p122 

    The article focuses on the U.S. Senate Finance Committee's hearing titled "Anatomy of a Fraud Bust: From Investigation to Conviction" held on April 24, 2012 on Medicare fraud. The hearing included representatives of the U.S. government agencies including the Centers for Medicare and Medicaid...

  • OIG to initiate voluntary disclosure program.  // hfm (Healthcare Financial Management);Nov94, Vol. 48 Issue 11, p6 

    Reports on the Department of Health and Human Services (HHS) Office of the Inspector General and the Department of Justice's (DOJ) development of a program for reporting violations of employees of healthcare providers. Incentives offered by the program.

  • Implication of the laboratory charges unbundling initiative. Kendall, Michael // hfm (Healthcare Financial Management);Dec97, Vol. 51 Issue 12, p64 

    Offers a look at the joint initiative of the US Health and Human Services (HHS) Office of the Inspector General and the Department of Justice (DOJ) on laboratory charges unbundling. Details of the initiative; How the DOJ is implementing the program; How hospitals can limit their exposure under...

  • OIG and DOJ Target Pneumonia Upcoding and Transfer Violations.  // hfm (Healthcare Financial Management);Mar99, Vol. 53 Issue 3, p9 

    States that the United States (US) Office of Inspector General (OIG) and Department of Justice (DOJ) have targeted for prosecution hospitals that upcode pneumonia cases and violate transfer rules. Comments from US Deputy Attorney General Eric H. Holder on the violations.

  • Court report.  // Medical Device Daily;2/20/2008, Vol. 12 Issue 34, p4 

    The article reports that a subpoena has been received by Hill-Rom, the medical technology business of Hillenbrand Industries, from the U.S. Attorney's Office in Tennessee, according to a filing with the U.S. Securities and Exchange Commission. The filing revealed that the company is being asked...

  • Industry Growth Draws OIG's Interest.  // Eli's Home Care Week;10/ 8/2012, Vol. 21 Issue 35, p279 

    The article informs that increase growth of industry in the U.S. draws the interest of the U.S. Department of Health & Human Services (HHS). Office of Inspector General (OIG) for surety bond requirements. It highlights that Medicare spending on home health grows from four billion U.S. dollar in...

  • DaVita Announces Government Inquiry.  // Biomedical Market Newsletter;10/31/2011, Vol. 21, p1266 

    The article reports that leading kidney care services provider DaVita Inc. will be subjected to a government inquiry from the Office of the Inspector General for the U.S. Department of Human and Health Services (DHHS). The inquiry is in relation to the payment for infusion drugs covered by the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics